BlackRock Group’s Assembly Biosciences ASMB Stock Holding History

BlackRock Group’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-214	Closed	-$37K	–	2668
2013 Q3	$37K	Buy	+214	New	+$32.8K	﹤0.01%	2747

Other funds holding ASMB

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Group's ASMB Position: Q4 2013 in Review

BlackRock Group sold out of Assembly Biosciences (ASMB) in Q4 2013, closing a stake of 214 shares — an estimated $37K sold.

BlackRock Group first reported a position in ASMB in Q3 2013 and held it in 1 quarter. The position peaked at $37K in Q3 2013. 34 funds tracked by Wall St. Rank hold ASMB as of Q4 2013.

BlackRock Group reported no remaining Assembly Biosciences position as of Q4 2013 after selling out during the quarter.
BlackRock Group sold 214 Assembly Biosciences shares in Q4 2013, an estimated $37K.
BlackRock Group first reported a position in Assembly Biosciences in Q3 2013 and held it in 1 quarter.
BlackRock Group's Assembly Biosciences position peaked at $37K in Q3 2013.
34 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.